Published: Dec 19, 2017
HARRISBURG, Pennsylvania and PHOENIXVILLE, Pennsylvania.–(BUSINESS WIRE)—Affinity Bio Partners Affinity BioCeuticals and HCXperience (HCXP) announced that they are technology partners.
HCXP is leading the way in improving the client experience through electronic real-time software development. HCXP (supports, monitors, maintains) clients and partners nationwide who are focused on implementing and impacting change in data capture and data-base reporting.
“HCXP is proud to announce its partnership with Affinity Bio Partners and Affinity BioCeuticals. As the exclusive technology partner for each of the Affinity companies, we will provide our technology solutions to help facilitate meaningful data for clinical trials in a regulated manner. This is an exciting opportunity to serve healthcare together.” Wayne Kelly, Founder HCXP
“Affinity Bio Partners and Affinity BioCeuticals’ are very pleased to announce this very strategic technology partnership with HCXP. For each of my organizations, it is with great importance to ensure that all of our data generated for our clients’ needs as well as our needs for clinical trials that we are sponsoring are done happen in real time and with compliance. We are thrilled to be collaborating with HCXP.” said Christina DiArcangelo Puller, CEO, Affinity Bio Partners and Affinity BioCeuticals.
About HCXperience Inc. (HCXP)
HCXP is a Pennsylvania based company that provides innovative healthcare solutions and services.
HCXP has clients and partners throughout the country working in tandem to impact change and how healthcare experience data is captured/reported.
Affinity Bio Partners is a Clinical Research Organization (CRO) that provides best in class services while maintaining a personal approach. There are many CROs in the market, but there is only one that will give our client’s organization the attention, services and results. Affinity BioCeuticals’, is Medical Cannabis Biotech organization in the United States. Affinity BioCeuticals’ belief is that the potential healing powers of Medical Cannabis and its derivatives must be explored through clinical research. To that end, Affinity BioCeuticals’ will ensure that Medical Cannabis is utilized in the appropriate manner while adhering to the highest safety practices in dosing protocols and delivery methods.
For more information on the company or general inquiries, please email: email@example.com or visit us at www.affinitybiopartners.com. Follow us on twitter, Facebook, LinkedIn and Instagram.